| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
B cells help CD8+ T-cell responses
|
Peng, Jun
|
|
|
127 |
6 |
p. 667-669
|
artikel
|
| 2 |
BCR-ABL1 mutation ≠ ponatinib resistance
|
Saglio, Giuseppe
|
|
|
127 |
6 |
p. 666-667
|
artikel
|
| 3 |
CD20+ B-cell depletion therapy suppresses murine CD8+ T-cell–mediated immune thrombocytopenia
|
Guo, Li
|
|
|
127 |
6 |
p. 735-738
|
artikel
|
| 4 |
Clinical efficacy and management of monoclonal antibodies targeting CD38 and SLAMF7 in multiple myeloma
|
van de Donk, Niels W.C.J.
|
|
|
127 |
6 |
p. 681-695
|
artikel
|
| 5 |
Compound mutations in BCR-ABL1 are not major drivers of primary or secondary resistance to ponatinib in CP-CML patients
|
Deininger, Michael W.
|
|
|
127 |
6 |
p. 703-712
|
artikel
|
| 6 |
CRISPR/Cas9-mediated conversion of human platelet alloantigen allotypes
|
Zhang, Nanyan
|
|
|
127 |
6 |
p. 675-680
|
artikel
|
| 7 |
Dameshek W. Some speculations on the myeloproliferative syndromes [editorial]. Blood. 1951;6(4): 372-375
|
|
|
|
127 |
6 |
p. 663
|
artikel
|
| 8 |
Editorial Board
|
|
|
|
127 |
6 |
p. i
|
artikel
|
| 9 |
Effect of lenalidomide treatment on clonal architecture of myelodysplastic syndromes without 5q deletion
|
Chesnais, Virginie
|
|
|
127 |
6 |
p. 749-760
|
artikel
|
| 10 |
Familial hypertriglyceridemia manifests with pancytopenia and bone marrow pseudo–Niemann-Pick cells
|
Sandoval-Sus, Jose D.
|
|
|
127 |
6 |
p. 787
|
artikel
|
| 11 |
FOXO1 activation is an effector of SYK and AKT inhibition in tonic BCR signal-dependent diffuse large B-cell lymphomas
|
Szydlowski, Maciej
|
|
|
127 |
6 |
p. 739-748
|
artikel
|
| 12 |
FOXO discriminates tonic from chronic in DLBCL
|
Efremov, Dimitar G.
|
|
|
127 |
6 |
p. 669-670
|
artikel
|
| 13 |
Gas6 fueling tumor-mediated thrombosis
|
Happonen, Kaisa E.
|
|
|
127 |
6 |
p. 672-673
|
artikel
|
| 14 |
How I treat recurrent deep-vein thrombosis
|
Kyrle, Paul A.
|
|
|
127 |
6 |
p. 696-702
|
artikel
|
| 15 |
Induction of WT1-specific human CD8+ T cells from human HSCs in HLA class I Tg NOD/SCID/IL2rgKO mice
|
Najima, Yuho
|
|
|
127 |
6 |
p. 722-734
|
artikel
|
| 16 |
KIT D816V–mutated bone marrow mesenchymal stem cells in indolent systemic mastocytosis are associated with disease progression
|
Garcia-Montero, Andres C.
|
|
|
127 |
6 |
p. 761-768
|
artikel
|
| 17 |
Macrophage receptor SR-AI is crucial to maintain normal plasma levels of coagulation factor X
|
Muczynski, Vincent
|
|
|
127 |
6 |
p. 778-786
|
artikel
|
| 18 |
Origin of stem cells in the BM niche: new clues from mastocytosis
|
Nemeth, Krisztian
|
|
|
127 |
6 |
p. 670-672
|
artikel
|
| 19 |
Panobinostat plus bortezomib and dexamethasone in previously treated multiple myeloma: outcomes by prior treatment
|
Richardson, Paul G.
|
|
|
127 |
6 |
p. 713-721
|
artikel
|
| 20 |
Platelet antibody identification: toward a solution
|
Skogen, Bjørn
|
|
|
127 |
6 |
p. 665-666
|
artikel
|
| 21 |
Prostaglandin E synthase is upregulated by Gas6 during cancer-induced venous thrombosis
|
Aghourian, Meghedi N.
|
|
|
127 |
6 |
p. 769-777
|
artikel
|
| 22 |
Signet ring plasma cell myeloma
|
Gralewski, Jonathan H.
|
|
|
127 |
6 |
p. 788
|
artikel
|
Tijdschrift beschrijving